Inventor · disambiguated record
Kyle Havens
Also filed as: HAVENS KYLE
8 granted patents·8 pending applications·32 citations·filing 2017–2025
82Inventor score
Top patents by PatentIndex Score
16 records- 0194US10927367B2CBLB endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2019·Granted Feb 23, 2021·13 cites·12 claims
- 0294US10793843B2CBLB endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2019·Granted Oct 6, 2020·13 cites·9 claims
- 0388US11779654B2PCSK9 endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2018·Granted Oct 10, 2023·5 cites·15 claims
- 0485US11732255B2CBLB endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2021·Granted Aug 22, 2023·1 cites·15 claims
- 0576US2024189454A1Pcsk9 endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2023·Application pending·0 cites
- 0671US2025327049A1Cblb endonuclease variants, compositions, and methods of useREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0770US12297465B2CBLB endonuclease variants, compositions, and methods of useREGENERON PHARMA·Filed 2021·Granted May 13, 2025·0 cites·7 claims
- 0870US2025262323A1Pcsk9 endonuclease variants, compositions, and methods of useNOVO NORDISK AS·Filed 2025·Application pending·0 cites
- 0970US2025179469A1Cblb endonuclease variants, compositions, and methods of useREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1068US12227740B2CBLB endonuclease variants, compositions, and methods of useREGENERON PHARMA·Filed 2018·Granted Feb 18, 2025·0 cites·11 claims
- 1167US2025368973A1Homing endonuclease variantsNOVO NORDISK AS·Filed 2025·Application pending·0 cites
- 1256US12404500B2Homing endonuclease variantsNOVO NORDISK AS·Filed 2019·Granted Sep 2, 2025·0 cites·20 claims
- 1346US2021002621A1Ctla4 homing endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2018·Application pending·0 cites
- 1443US11530395B2TGFBetaR2 endonuclease variants, compositions, and methods of use2SEVENTY BIO INC·Filed 2017·Granted Dec 20, 2022·0 cites·19 claims
- 1542US2019309274A1Il-10 receptor alpha homing endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2017·Application pending·0 cites
- 1639US2019262398A1Tim3 homing endonuclease variants, compositions, and methods of useBLUEBIRD BIO INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kyle Havens files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →